Avandia
Takeda Pharmaceuticals determined to gain FDA drug approval
- Mon, 05/14/2012 - 1:48pm
In a country bulging with 23 million people with type 2 diabetes, Avandia and its successor, Actos, were once blockbuster drugs in the U.S.
-
FDA approves new diet pill
- Jun 28, 2012
-
Diabetes Drug Could Increase Risk of Blindness
- Jun 14, 2012
-
What is a clinical trial?
- Jul 23, 2012
-
Actos recall not recommended by European health regulators
- Dec 21, 2011
-
Buying drugs online is risky business
- Jul 16, 2012
-
New Actos suits go straight to MDL
- Jun 29, 2012
-
FDA issues warning after codeine kills children post-surgery
- Aug 16, 2012
-
Artificial retina gives sight to blind mice
- Aug 16, 2012
-
Lucentis approved for diabetic macular edema
- Aug 14, 2012
-
Mayo Clinic: Patients in the dark about prescriptions
- Aug 9, 2012
-
Hospital's plan to prevent painkiller abuse
- Aug 8, 2012
-
Alzheimer's drug disappoints
- Aug 8, 2012
lawsuits femur fractures FDA EMA Fen-Phen medical malpractice statin diet drug listeria lawsuit lorcaserin metal-on-metal hip replacement ADHD meningitis kidney problems type 2 diabetes fentanyl patch chemotherapy Yaz blood thinners Johnson & Johnson lawsuits coumadin D.C. Avaira Tutorials Products Zimmer Warfarin Drugs stroke